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Abstract 
Objectives 
To examine associations between occupational exposures to rubber dust, rubber fumes, and N-
Nitrosamines and non-cancer disease mortality. 
 
Methods 
A cohort of 36,441 males aged 35+ years employed in British rubber factories was followed-up 
to 2015 (94% deceased). Competing risk survival analysis was used to assess risks of dying from 
non-cancer diseases (respiratory, urinary, cerebrovascular, circulatory, and digestive diseases). 
Occupational exposures to rubber dust, rubber fumes, N-Nitrosamines were derived based on a 
population-specific quantitative job-exposure matrix which in-turn was based on 
measurements in the EU-EXASRUB database. 
 
Results 
Exposure-response associations of increased risk with increasing exposure were found for N-
Nitrosomorpholine with mortality from circulatory diseases (Sub-hazard ratio (SHR) 1.2; 95%CI 
1.1-1.2), ischaemic heart disease (IHD) (SHR 1.2; 95%CI 1.1-1.3), cerebrovascular disease (SHR 
1.2; 95%CI 1.1-1.3), and exposures to N-Nitrosodimethylamine with respiratory disease 
mortality (SHR 1.4; 95%CI 1.3-1.5). Increased risks for mortality from circulatory disease, IHD, 
and digestive diseases were found with higher levels of exposures to rubber dust, rubber 
fumes, and N-Nitrosamines sum, without an exposure-dependent manner. No associations 
were observed between rubber dust, rubber fumes, and N-Nitrosamines exposures with 
mortality from asthma, urinary disease, bronchitis, emphysema, liver disease, and some 
digestive diseases. 
 
Conclusions 
In a cohort of rubber factory workers with 49 years of follow-up, increased risk for mortality 
from chronic circulatory, cerebrovascular, respiratory and digestive diseases were found to be 
associated with cumulative occupational exposures to specific agents.  
 
  
  
Key Messages 
What is already known about this subject? 
Occupational exposures in the rubber industry have been linked to various cancers and non-
cancer chronic diseases, including respiratory disease. 
 
What are the new findings? 
-Using one of the longest follow-ups of a rubber factory cohort, this study updates assessments 
of exposure-response associations between occupational exposures and lifetime non-cancer 
chronic disease mortality 
-Exposure response associations of increased risk with increasing exposure were found for 
exposures to NDMA with respiratory disease mortality and NMor with cerebrovascular disease 
mortality. 
-Occupational exposures in the rubber industry were not associated with mortality from urinary 
diseases, liver disease, or certain digestive and respiratory diseases. 
 
How might this impact on policy or clinical practice in the foreseeable future? 
This study clarifies that occupational exposures in the rubber industry extends beyond 
premature mortality risks from cancers to other chronic diseases, and this may have 
implications for current health and safety practices in the industry in the UK and worldwide.  
  
Introduction 
Occupational exposures in the rubber industry have been linked to increased risks of 
cancer incidence and mortality, as well as some non-cancer outcomes; particularly respiratory 
diseases.1–7 Analyses of the same British rubber factory workers cohort that the current study is 
based on documented higher standardized mortality ratios (SMRs) from cancer and non-cancer 
causes of deaths compared to the general population.3 Further internal analyses of the same 
cohort observed exposure-response associations between occupational exposures to agents 
such as rubber dust, rubber fumes, and Nitrosamines with cancer mortality. However, these 
studies did not examine associations between occupational exposures and non-cancer 
mortality.8 The evidence of whether specific exposures encountered in the rubber industry 
could be associated with higher premature mortality risks from non-cancer chronic diseases, 
however, is equivocal. Some studies3,9,10, but not all11,12, have found increased mortality from 
circulatory disease, cerebrovascular disease, and respiratory diseases compared to the overall 
population, as well as within rubber factory worker cohorts; particularly in compounding, 
milling, and vulcanizing departments. Studies where no associations were observed11,12 had 
smaller samples and shorter follow-ups. A systematic review of non-malignant respiratory 
disease amongst rubber factory workers found supporting evidence for higher respiratory-
related morbidities, but inconsistent evidence for mortality from non-malignant respiratory 
disease.13 
Within the rubber production process, workers perform specific work tasks that are 
organized by department, where the following operations typically take place: handling raw 
and synthetic materials, milling, extruding and calendering, component assembly, curing or 
  
vulcanizing, finishing, and storage/dispatch.1 Tasks within each production operation define 
workers’ interactions with raw materials and chemical additives, leading to variations in the 
types of agents to which they are exposed and the levels of exposures to these agents. 
Variations in occupational exposures between different departments in rubber factories may 
play a role in the development of chronic diseases as they do in cancer incidence and 
mortality8, and may have consequences on mortality rates from these diseases. In the 
beginning of the rubber production process, where raw and synthetic materials are handled by 
workers, rubber dust exposure tends to occur at the highest levels.1 The milling process 
involves generating a substantial amount of heat which then generates and exposes workers to 
rubber fumes, as does the next part of the production process of extrusion and calendering.1 
The vulcanizing and curing processes likewise apply heat in addition to mixtures of chemical 
additives, which in turn generate fumes and N-Nitrosamines.1 In previous research, using 
expert-estimated exposures based on job titles, workers in compounding, mixing, and milling 
departments were found to have higher mortality from circulatory disease, ischaemic heart 
disease (IHD), respiratory, and digestive diseases while workers in vulcanizing departments had 
higher mortality from circulatory and respiratory diseases compared to the general 
population.10 The current study seeks to examine whether occupational exposures to rubber 
dust, rubber fumes, and N-Nitrosamines within a cohort of UK rubber workers with 49-year 
follow-up and nearly complete mortality, are associated with mortality from non-cancer chronic 
diseases in an exposure-response fashion. 
Materials and Methods 
Data 
  
This study used data from a UK cohort of male rubber factory workers who were 
employed in 381 factories and were aged 35-55 in February 1967 (N=36,441). This cohort was 
followed for mortality until December 2015 when 93.8% (N=34,181) of the cohort had died and 
0.4% (N=136) attrited prior to death mainly through emigration, resulting in 880,794 person 
years for the statistical analyses. Full details of the cohort as well as analyses of cancer 
mortality and comparisons to the general population have been described elsewhere.3,8 
Job title in 1967 for each worker was linked to a quantitative job-exposure matrix (JEM) 
based on the EU-EXASRUB database which contains personal and stationary measurements of 
exposure to various agents in rubber factories in Europe.14 Average exposure was estimated 
based on a linear (in log-space) mixed effects model with random factory intercept. From these 
estimates, lifetime cumulative exposures (LCE) were calculated for each person. Similar to the 
analyses of cancer mortality of the same cohort8, because only job information in 1967 was 
available, the primary analyses assumed continuous employment in this same department until 
retirement at age 70 (chosen because there was substantial employment in the rubber industry 
among men in their 60’s), death, or emigration. LCEs were calculated separately for exposures 
to rubber dust, rubber fumes (measured as the cyclohexane soluble fraction of rubber dust), 
Nitrosamines sum score (a sum of exposures to N-Nitrosodimethylamine (NDMA), N-
Nitrosodiethylamine (NDEA), N-Nitrosodibutylamine, N-Nitrosopiperidine (NPIP), and N-
Nitrosomorpholine (NMor)), and NDMA and NMor individually. Full details of the JEM 
development, LCE construction and distributions have been described elsewhere.8 Sensitivity 
analyses for selected chronic disease mortality outcomes and employment durations were 
conducted based on random assignment of employment durations based on the distribution of 
  
the employment history of a similar UK cohort of which this study is a part of15 with the 
following parameters: 47% of cohort employed for >10 years after 1967 and 12% were 
employed for >18 years. 
Outcomes were mortality from the following chronic diseases as listed in the death 
certificate as underlying causes of death (Table 1): circulatory disease, ischemic heart disease 
(IHD), cerebrovascular disease, respiratory diseases, asthma, bronchitis, emphysema, urinary 
diseases, liver disease, diseases of the oesophagus, stomach and duodenum, and digestive 
diseases. Respiratory diseases include a broad range of conditions such as acute upper 
respiratory infections, influenza and pneumonia, and chronic lower respiratory diseases 
(including bronchitis, asthma, and emphysema). Contributing causes of death data were not 
used because MCD information was not digitized for a large number of death certificates from 
the early part of the study. Furthermore, historical death certificates would have been sensitive 
to changes in coding practices, which may not have become consistent across the UK until after 
1980s.16 All models were adjusted for birth year (mean age in 1967 is 50.1 years, S.D.=8.4) and 
LCE to rubber dust, rubber fumes, and N-Nitrosamines (separate models as well as multi-
pollutant models). LCEs are grouped in quartiles of the cumulative exposure distribution in the 
cohort and analyzed separately as continuous variables to assess the linearity of the exposure-
response association.  
Statistical Methods 
Competing risk survival analysis was used to model time to death from the selected non-
cancer chronic disease cause, or occurrence of a competing event (death from another cause or 
censored through attrition or emigration)17. This method was selected because in analyzing 
  
specific causes of deaths using a high mortality cohort such as ours (93.8%), the assumptions of 
random occurrence and independence of censored deaths from other causes in a standard Cox 
proportional hazard model would have been violated. Statistical analyses were performed using 
stcrreg in Stata 15.018 which yielded sub-distribution hazard ratios (SHRs) that could be 
interpreted in a similar manner to hazard ratios such as in Cox models.19 Full details of the 
statistical method are described elsewhere.8 
Results 
Non-cancer chronic disease mortality was examined amongst 36,441 male rubber 
factory workers who were at least 35 years old in 1967 and followed for mortality until 2015, 
resulting in 880,794 person-years. The highest proportion of deaths were from circulatory 
diseases, comprising 40.1% of all deaths (N=14,627), specifically most of which were from IHD 
(N=9,349) (Table 1). The second highest proportion of deaths were from respiratory diseases, 
which accounted for 13.0% (N=4,730), and cerebrovascular disease, accounting for 7.7% 
(N=2,795) of all deaths.   
Rubber dust exposures (Table 2) in the higher LCE quartiles (2nd-4th quartiles) were 
found to be associated with increased risks for mortality from circulatory disease (SHRs up to 
1.2; 95%CI 1.1-1.2), IHD (SHRs up to 1.2; 95%CI 1.1-1.3), cerebrovascular disease (SHRs up to 
1.2; 95%CI 1.1-1.4), respiratory diseases (SHRs up to 1.2; 95%CI 1.1-1.3) and digestive diseases 
(SHRs up to 1.4; 95%CI 1.1-1.6). These results were supported by the sensitivity analyses, which 
showed in all simulated employment duration models, higher levels of exposures were 
associated with higher risks of dying from these diseases (Supplemental Figures 1-5). Results for 
mortality from liver disease and diseases of the oesophagus, stomach, and duodenum showed 
  
increased risks for higher levels of exposures to rubber dust, but with wide confidence intervals 
and not statistically significant. No evidence was found for excess risks of deaths from asthma, 
urinary disease, bronchitis and emphysema with higher levels of exposures to rubber dust.  
Higher LCE (2nd-4th quartiles) to rubber fumes (Table 2) were also found to be 
associated with increased risks of dying from circulatory diseases (SHRs up to 1.2; 95% CI 1.2-
1.3), IHD (SHRs up to 1.2; 95%CI 1.1-1.3), cerebrovascular disease (SHRs up to 1.3; 95%CI 1.2-
1.5), respiratory diseases (SHRs up to 1.3; 95%CI 1.2-1.4), and digestive diseases (SHRs up to 
1.7; 95%CI 1.4-2.0). Similar to results from rubber dust exposure, increased risks for mortality 
with higher levels of exposures to rubber fumes were observed in a monotonic exposure-
response pattern. These results were not undermined by the sensitivity analyses (Supplemental 
Figures 1-5). 
Higher LCEs of N-Nitrosamines sum score (2nd - 4th quartiles) (Table 3) was associated 
with increased mortality risk from circulatory diseases (SHRs up to 1. 3; 95%CI 1.2-1.3), IHD 
(SHRs up to 1.3; 95%CI 1.2-1.4), cerebrovascular disease (SHRs up to 1.5; 95%CI 1.3-1.6), 
respiratory diseases (SHRs up to 1.5; 95%CI 1.4-1.6), and digestive diseases (SHRs up to 1.6; 
95%CI 1.3-2.0). Comparable to rubber dust and rubber fumes exposures, exposure-response 
patterns were not observed, although all higher quartiles of exposures were found to have 
higher mortality risks compared to the 1st quartile (reference category). These results were 
supported by the sensitivity analyses (Figures 1-5). No evidence of increased risks of mortality 
from asthma, bronchitis, diseases of the oesophagus, stomach, and duodenum, urinary 
diseases, and liver disease associated with N-Nitrosamines exposures were found. 
  
Exposure-response patterns were observed for NDMA and mortality from respiratory 
diseases (SHRS up to 1.4; 95%CI 1.3-1.5) (Table 3). Increased risks without linear associations 
were found for mortality from circulatory diseases (SHRs up to 1.4; 95%CI 1.3-1.4), IHD (SHRs 
up to 1.4; 95%CI 1.3-1.5), cerebrovascular disease (SHRs up to 1.4; 95%CI 1.2-1.5), and digestive 
diseases (SHRs up to 1.7; 95%CI 1.4-2.0). These results were supported by the sensitivity 
analyses (Supplemental Figures 1-5). Other chronic diseases where specific quartiles of 
exposures were associated with increased risks were found for mortality from urinary diseases 
(3rd quartile SHR=1.6; 95%CI 1.1-2.3) and liver disease (3rd quartile SHR=2.2; 95%CI 1.2-4.0). 
Exposures to NDMA were not associated with mortality from asthma, bronchitis, emphysema, 
and diseases of the oesophagus, stomach, and duodenum. 
Increased risks of dying from several chronic diseases were found to be associated with 
higher levels of LCEs to NMor (Table 3): circulatory diseases (SHRs up to 1.2; 95%CI 1.1-1.2), IHD 
(SHRs up to 1.2; 95%CI: 1.1-1.3), and cerebrovascular disease (SHRs up to 1.2; 95%CI 1.1-1.3). 
Exposure-response patterns were observed for these associations where mortality risks 
increase with higher levels of NMor exposures. These results were supported by the sensitivity 
analyses (Supplemental Figures 1-5). Increased mortality risk from respiratory diseases were 
also found with the 2nd and 3rd quartiles of NMor exposures (SHRs up to 1.2; 95%CI 1.1-1.3). 
Premature risk of mortality from asthma, urinary diseases, bronchitis, digestive diseases, 
emphysema, liver disease, and diseases of the oesophagus, stomach, and duodenum were not 
associated with LCE to NMor. 
Multi-pollutant models with exposures to rubber dust, rubber fumes, and NSS were 
conducted (Table 4) for a subset of causes of deaths with the highest proportions. Excess risks 
  
of dying from cerebrovascular disease without exposure-response patterns were only found for 
NSS exposures (SHRs up to 1.4; 95%CI 1.3-1.7). For circulatory disease, higher risks of dying 
were found for rubber dust exposures (SHRs up to 1.1; 95%CI 1.1-1.2), rubber fume exposures 
(SHRs up to 1.1; 95%CI 1.01-1.2), and NSS (SHRs up to 1.2; 95%CI 1.1-1.3). For IHD, higher risks 
of dying were found for LCE to rubber dust (SHRs up to 1.2; 95%CI 1.1-1.2) and NSS (SHRs up to 
1.2; 95% CI 1.1-1.3), but risks for higher LCE to rubber fumes were not different from the lowest 
exposed reference group. For digestive diseases, higher risks of dying were found with higher 
exposures of rubber fumes (SHRs up to 1.4; 95%CI 1.1-1.8) and NSS (SHRs up to 1.4; 95%CI 1.1-
1.8), and not rubber dust exposures of any level. For respiratory disease, higher risks of dying 
were found for LCE to rubber dust (SHRs up to 1.1; 95%CI 1.02-1.2), rubber fumes (SHRs up to 
1.2; 95%CI 1.1-1.4), and NSS (SHRs up to 1.4; 95%CI 1.3-1.6). 
Discussion 
We examined associations between occupational exposures to rubber dust, rubber 
fumes, and nitrosamines with non-cancer chronic disease mortality amongst a cohort of UK 
rubber factory workers with a 49-year follow-up. Consistent with previous studies1–7, we 
observed increased risk for respiratory disease mortality and through examining exposures to 
specific agents, we were able to link the excess risk to workers with higher levels of exposures 
to rubber dust, rubber fumes, NDMA, and NSS. We also found increased risk for circulatory 
disease mortality, consistent with previous studies3,9,10, associated with higher levels of 
occupational exposures to rubber dust, rubber fumes, and NSS. Furthermore, this study found 
that higher occupational exposures to NMor were associated with higher risks for 
cerebrovascular disease mortality and IHD. A previous analysis of the same cohort as the 
  
current study also found higher SMRs amongst rubber workers compared to the general 
population for mortality from IHD (SMR=1.1; 95%CI 1.06-1.10), circulatory disease (SMR=1.07; 
95%CI 1.05 to 1.1), respiratory diseases (SMR=1.1; 95%CI 1.1-1.2), and cerebrovascular disease 
(SMR=1.04; 95%CI 1.0 to 1.1).3 We found increased risks for non-malignant digestive disease 
mortality with higher levels of exposures to rubber dust, rubber fumes, and NSS, unlike several 
previous studies with shorter follow-up and smaller sample sizes.11,12 A Bonferroni correction 
for multiple comparisons was applied to the results for each cause of death/agent combination, 
with p-values lower than 0.0009 for 55 distinct analyses to be considered robust. We found that 
several p-values met these criteria, namely for cardiovascular and IHD mortality for all agents, 
cerebrovascular disease mortality for rubber fumes, NSS, and NDMA LCEs, respiratory disease 
mortality for all agents except NMor LCEs, and for digestive disease mortality and NDMA LCEs.  
In multi-pollutant models, excess risks of dying from cerebrovascular, circulatory, 
digestive, respiratory diseases and IHD were only found for NSS exposure, but linear exposure-
response associations were not observed. However, the single-pollutant approach has typically 
been used in previous studies due to issues related to  correlations between pollutants and 
different levels of measurement error for different pollutants.20 No associations were observed 
between occupational exposures to rubber dust, rubber fumes and N-Nitrosamines with 
premature mortality from asthma, urinary diseases, bronchitis, emphysema, liver disease, and 
diseases of the oesophagus, stomach and duodenum. Previous studies also found no excess 
risks of mortality from liver and urinary disease in the rubber industry.11,12 
Taken together, results from single and multi-pollutant models suggest a pattern of 
increased mortality from non-cancer diseases with higher quartiles of lifetime exposures in the 
  
rubber industry. Because most previous studies focused on the carcinogenic effects of these 
exposures, the exact biological mechanism linking these exposures to non-cancer diseases have 
not been clearly elucidated albeit excess risks for both heart disease and cancer has been 
previously reported21,22. Nevertheless, two possible mechanisms have been suggested in 
previous studies: the inflammatory pathway, which suggests that exposures to rubber dust lead 
to pulmonary system inflammation which leave workers more susceptible to cardiovascular 
disease,23 and the DNA damage pathway, which suggests that increased genotoxic risks faced 
by rubber factory workers contribute to DNA damage24,25 resulting in increased susceptibility to 
the formation of atherosclerotic plaques26, further contributing to cardiovascular disease, 
similar to a mechanism suggested from exposures to toxic metal contaminates27 and which has 
also been reported for IHD amongst asphalt workers.28 
The main strength of this study is the 49-year follow-up period, one of the longest 
follow-ups of rubber factory worker cohorts in the world and the longest in the UK.  This 
allowed for a high cohort mortality rate (94%) with minimal attrition through emigration (0.4%), 
making it particularly suitable to examine mortality from chronic diseases. Furthermore, given 
the previous focus on cancer in the rubber industry, this is one of few studies to date to 
examine non-cancer chronic disease mortality amongst rubber factory workers. Lastly, through 
the use of job-exposure matrices, this study was able to utilize data from a historical cohort 
without contemporaneous exposure measurements to quantitatively examine associations 
between occupational exposures and non-cancer chronic disease mortality. Sensitivity analyses 
were conducted with alternative simulated employment durations based on information on 
employment durations from another, partly overlapping, cohort of British rubber factory 
  
workers6,15,29 and showed that results of the main analyses are robust. Although exposure 
estimates from job-exposure matrices are generated from mean exposure values and therefore 
do not allow for individual variabilities, errors that arise from them tend to be attenuated 
Berkson-type errors, which, unlike random errors, generally do not bias exposure-response 
associations.30–32 Finally, exposure-specific estimates of LCE enabled multi-pollutant models to 
explore issues of complex exposure mixtures across the production process. 
The main limitations for this study includes a lack of control for lifestyle factors or 
baseline health status such as smoking, body mass index (BMI), physical fitness, or blood 
pressure, which could be related to the development of non-cancer chronic diseases.33 Because 
smoking was highly prevalent amongst all adult males in 1967 (estimated at 54%)34 and a 
similar smoking prevalence was reported in a more recent cohort of UK rubber factory 
workers35, health risks associated with smoking, which has been reported to have the strongest 
associations with mortality amongst these lifestyle factors36 could have been distributed 
similarly across the cohort of rubber factory workers in this analysis. Nevertheless, sensitivity 
analyses results showed that a small proportion of simulations were affected by the residual 
confounding of smoking status (full details in Online Supplemental Materials). These results 
imply that confounding from unmeasured smoking status in this study was unlikely, but cannot 
be completely excluded. Previous research on occupational status inequalities suggests that 
workers in supervisory or managerial roles may have better health and have lower risks of dying 
from non-cancer chronic diseases.37 This could be applicable to our cohort as workers in these 
job roles may also have lower exposures to rubber process by-product agents.  Secondly, the 
study sample included workers who were at least age 35 at baseline, which could possibly be 
  
biased towards workers who were healthy enough to sustain employment and had not dropped 
out of employment due to ill-health, i.e. producing a “healthy worker effect”.38 However, this is 
less problematic for this study because it focuses on differences in mortality within the rubber 
factory worker cohort as opposed to comparing workers to the general population. Third, 
alternative metrics of exposures such as peak exposure could not be tested because of lack of 
exposure estimates covering the 49-year follow-up period. 
Conclusion 
This study is to our knowledge the first to examine exposure-response associations 
between specific occupational exposures in the rubber industry and non-cancer chronic disease 
mortality using quantitative exposures through a job-exposure matrix. The results are 
consistent with previous studies that similarly found variations in risks of non-cancer chronic 
disease mortality by department9,10 with elevated risks in compounding and mixing, milling, and 
vulcanizing. Because data on lifestyle factors including smoking were unavailable, effects of 
residual confounding on our results could not be dismissed. Although this study was based on a 
cohort employed in the rubber industry in 1967, the results continue to be relevant to the 
industry today, possibly in terms of worker health litigations and compensation in Europe and 
North America where rubber production facilities were located in the 20th century.  This study 
adds to the large body of research documenting associations between employment and specific 
workplace exposures in the rubber industry and chronic disease mortality.  
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Table 1. International Classification of Diseases (ICD) codes for selected chronic non-cancer 
causes of deaths 
 
Cause of death ICD 9 ICD 10 N Deaths 
Circulatory diseases 390-459 I00-I99 14,627 
Ischaemic heart disease 410-414 I20-I25 9,349 
Cerebrovascular disease 430-438 I60-I69 2,795 
Respiratory diseases 460-519 J00-J99 4,730 
Bronchitis 460-491 J40-J42 845 
Emphysema 492 J43 163 
Asthma 493 J45 63 
Digestive diseases 520-577 K00-K93 827 
Diseases of the 
oesophagus, stomach and 
duodenum 
530-537 K20-K31 258 
Liver disease 571 K70-K76 93 
Urinary diseases 580-599 N00-N39 253 
Total deaths from all 
causes 
  34,181 
 
 
  
  
Table 2. Risk of death from selected chronic diseases by lifetime cumulative exposure to rubber 
dust and rubber fumes in a cohort of rubber factory workers in the UK 
 
 
Chronic Disease 
 
N 
Cumulative Rubber Dust 
(year mg/m3) 
Cumulative Rubber Fumes 
(year mg/m3) 
Exposurea SHRb 95%CI Exposurec SHRb 95%CI 
Asthma 
 
63 I 1.00  I 1.00  
 II 1.20 0.61 – 2.35 II 1.31 0.62 – 2.76 
 III 1.21 0.62 – 2.37 III 1.42 0.67 – 3.02 
 IV 0.96 0.46 – 2.00 IV 1.74 0.90 – 3.36 
P for trend   0.29   0.18  
Urinary 253 I 1.00  I 1.00  
 II 0.87 0.60 – 1.27 II 1.19 0.85 – 1.65 
 III 1.17 0.84 – 1.64 III 1.15 0.81 – 1.63 
 IV 1.26 0.91 – 1.73 IV 1.13 0.82 – 1.57 
P for trend   0.91   0.65  
Bronchitis 845 I 1.00  I 1.00  
 II 1.11 0.92 – 1.33 II 1.01 0.84 – 1.22 
 III 0.85 0.70 – 1.04 III 0.88 0.71 – 1.08 
 IV 0.92 0.77 – 1.10 IV 1.04 0.87 – 1.23 
P for trend   1.00   0.87  
Cerebrovascular 2,795 I 1.00  I 1.00  
 II 1.17 1.05 – 1.30 II 1.27 1.14 – 1.41 
 III 1.23 1.11 – 1.37 III 1.31 1.18 – 1.46 
 IV 1.16 1.04 – 1.28 IV 1.21 1.09 – 1.34 
P for trend   0.57   0.85  
Circulatory 14,627 I 1.00  I 1.00  
 II 1.15 1.10 – 1.20 II 1.18 1.12 – 1.23 
 III 1.19 1.14 – 1.25 III 1.22 1.17 – 1.28 
 IV 1.19 1.13 – 1.24 IV 1.18 1.13 – 1.23 
P for trend   0.57   0.48  
Digestive 827 I 1.00  I 1.00  
 II 1.35 1.12 – 1.64 II 1.67 1.38 – 2.02 
 III 1.24 1.02 – 1.52 III 1.40 1.14 – 1.71 
 IV 1.34 1.10 – 1.63 IV 1.42 1.16 – 1.73 
P for trend   0.003   <0.001  
Emphysema 163 I 1.00  I 1.00  
 II 1.05 0.68 – 1.62 II 1.25 0.83 – 1.87 
 III 0.86 0.55 – 1.34 III 0.97 0.63 – 1.48 
 IV 1.17 0.78 – 1.77 IV 0.91 0.59 – 1.39 
P for trend   0.48   0.48  
IHD 9,349 I 1.00  I 1.00  
 II 1.18 1.11 – 1.25 II 1.18 1.11 – 1.25 
 III 1.23 1.16 – 1.30 III 1.21 1.14 – 1.29 
 IV 1.22 1.15 – 1.29 IV 1.17 1.10 – 1.23 
P for trend   0.76   0.79  
Liver 93 I 1.00  I 1.00  
  
 II 1.47 0.85 – 2.53 II 1.33 0.75 – 2.33 
 III 1.36 0.77 – 2.40 III 1.45 0.82 – 2.54 
 IV 1.00 0.53 – 1.88 IV 1.04 0.57 – 1.90 
P for trend   0.62   0.95  
Oesophagus, 
stomach and 
duodenum 
 
258 I 1.00  I 1.00  
 II 1.20 0.85 – 1.69 II 1.37 0.98 – 1.92 
 III 1.20 0.85 – 1.70 III 1.17 0.81 – 1.69 
 IV 1.20 0.85 – 1.68 IV 1.36 0.97 – 1.89 
P for trend   0.003   <0.001  
Respiratory 4,730 I 1.00  I 1.00  
  II 1.21 1.12 – 1.31 II 1.29 1.19 – 1.40 
  III 1.18 1.09 – 1.28 III 1.27 1.17 – 1.38 
  IV 1.15 1.06 – 1.24 IV 1.28 1.18 – 1.38 
P for trend   0.85   0.91  
 
aBased on quartiles (I: <14.73 year mg/m3; II: 14.73-21.05 year mg/m3; III: 21.05-31.42 year 
mg/m3; IV:>31.42 year mg/m3) of the cumulative distribution in the population 
bSub-hazard ratio from competing risk survival analysis model adjusted for birth year 
cBased on quartiles (I: <4.89 year mg/m3; II: 4.89-6.96 year mg/m3; III: 6.96-11.61 year mg/m3; 
IV:>11.61 year mg/m3) of the cumulative distribution in the population 
 
  
Table 3. Risk of death from selected chronic diseases by lifetime cumulative exposure to Nitrosamines sum score (NSS), N-nitrosodimethylamine 
(NDMA), and N-nitrosomorpholine (NMor) in a cohort of rubber factory workers in the UK 
 
 N Cumulative Nitrosamines Sum Score 
(NSS)a 
(year μg/m3) 
Cumulative NDMA 
(year μg/m3) 
Cumulative NMor  
(year μg/m3) 
Exposureb SHRc 95%CI Exposured SHRc 95%CI Exposuree SHRc 95%CI 
Asthma 
 
 
 
63 I 1.00   I 1.00   I      1.00    
II 1.38 0.63 – 2.99 II 1.38 0.63 – 2.99 II      1.73  0.85 – 3.53 
III 1.42 0.67 – 3.03 III 1.42 0.67 – 3.03 III      1.50  0.71 – 3.14 
IV 1.71 0.89 – 3.30 IV 1.71 0.89 – 3.30 IV      1.57  0.74 – 3.33 
P for trend   0.11    0.11        0.31    
Urinary 
 
 
 
253 I 1.00   I 1.00   I      1.00    
II 1.51 1.09 – 2.09 II 1.51 1.09 – 2.09 II      1.00  0.71 – 1.41 
III 1.24 0.88 – 1.76 III 1.24 0.88 – 1.76 III      1.05  0.74 – 1.48 
IV 0.91 0.64 – 1.29 IV 0.91 0.64 – 1.29 IV      0.98  0.7 – 1.38 
P for trend   0.73    0.73        0.58    
Bronchitis 
 
 
 
845 I 1.00   I 1.00   I      1.00    
II 0.94 0.77 – 1.16 II 0.94 0.77 – 1.16 II      1.02  0.85 – 1.22 
III 1.22 1.01 – 1.48 III 1.22 1.01 – 1.48 III      1.06  0.88 – 1.27 
IV 0.96 0.81 – 1.14 IV 0.96 0.81 – 1.14 IV      0.76  0.63 – 0.92 
P for trend   0.58    0.58      0.004    
Cerebrovascular 
 
 
 
2,795 I 1.00   I 1.00   I      1.00    
II 1.48 1.33 – 1.64 II 1.48 1.33 – 1.64 II      1.17  1.05 – 1.3 
III 1.36 1.21 – 1.51 III 1.36 1.21 – 1.51 III      1.17  1.05 – 1.3 
IV 1.27 1.15 – 1.41 IV 1.27 1.15 – 1.41 IV      1.19  1.07 – 1.32 
P for trend   0.69    0.69      0.003    
Circulatory 
 
 
 
14,627 
 
I 1.00   I 1.00   I      1.00    
II 1.28 1.22 – 1.34 II 1.28 1.22 – 1.34 II      1.09  1.04 – 1.14 
III 1.18 1.13 – 1.24 III 1.18 1.13 – 1.24 III      1.12  1.07 – 1.18 
IV 1.17 1.12 – 1.22 IV 1.17 1.12 – 1.22 IV      1.17  1.12 – 1.23 
P for trend   0.41    0.41     <0.001    
Digestive 
 
 
 
827 I 1.00   I 1.00   I      1.00    
II 1.60 1.31 – 1.95 II 1.60 1.31 – 1.95 II      1.15  0.95 – 1.39 
III 1.54 1.26 – 1.89 III 1.54 1.26 – 1.89 III      0.99  0.81 – 1.21 
IV 1.35 1.11 – 1.65 IV 1.35 1.11 – 1.65 IV      1.20  0.99 – 1.46 
  
P for trend   0.64    0.64        0.17    
Emphysema 
 
 
 
163 I  1.00   I   1.00    I 1.00   
II  1.21  0.81 – 1.78 II   1.34  0.88 – 2.03 II 1.14 0.73 – 1.76 
III  0.84  0.54 – 1.32 III   1.18  0.74 – 1.87 III 1.22 0.79 – 1.88 
IV  0.84  0.55 – 1.27 IV   1.49  0.98 – 2.27 IV 1.06 0.68 – 1.64 
P for trend    0.86      0.59     0.49   
IHD 
 
 
 
9,349 I  1.00   I   1.00    I 1.00   
II  1.29  1.22 – 1.37 II   1.24  1.18 – 1.32 II 1.10 1.04 – 1.17 
III  1.16  1.09 – 1.23 III   1.43  1.35 – 1.52 III 1.14 1.08 – 1.21 
IV  1.12  1.06 – 1.19 IV   1.28  1.20 – 1.36 IV 1.19 1.13 – 1.26 
P for trend    0.40      0.68     <0.001   
Liver 
 
 
 
93 I  1.00   I   1.00    I 1.00   
II  1.55  0.86 – 2.80 II   1.75  0.98 – 3.14 II 0.84 0.48 – 1.49 
III  1.31  0.73 – 2.35 III   2.22  1.24 – 3.99 III 1.03 0.60 – 1.79 
IV  1.34  0.75 – 2.39 IV   1.35  0.73 – 2.49 IV 1.04 0.59 – 1.84 
P for trend    0.32      0.34     0.88   
Oesophagus, 
stomach and 
duodenum 
258 I  1.00   I   1.00    I 1.00   
II  1.35  0.96 – 1.90 II   1.24  0.89 – 1.74 II 1.06 0.76 – 1.47 
III  1.43  1.01 – 2.03 III   1.40  0.99 – 1.99 III 1.02 0.73 – 1.43 
IV  1.06  0.75 – 1.50 IV   1.27  0.88 – 1.85 IV 0.76 0.53 – 1.09 
P for trend    0.79      0.68     0.29   
Respiratory 4,730 I  1.00   I   1.00    I 1.00   
  II  1.36  1.25 – 1.47 II   1.17  1.08 – 1.27 II 1.10 1.01 – 1.19 
  III  1.49  1.37 – 1.62 III   1.38  1.27 – 1.49 III 1.17 1.08 – 1.27 
  IV  1.28  1.18 – 1.38 IV   1.41  1.30 – 1.53 IV 1.07 0.99 – 1.16 
P for trend    0.27    0.92    0.51   
 
aSum of lifetime cumulative exposures to N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), N-nitrosodibutylamine, N-
nitrosopiperidine (NPIP), and N-nitrosomorpholine (NMor) 
bBased on quartiles (I: <17.24 year μg/m3; II: 17.24-26.72 year μg/m3; III: 26.72-546.51 year μg/m3; IV:>546.51 year μg/m3) of the cumulative 
distribution in the population 
cSub-hazard ratio from competing risk survival analysis model adjusted for birth year 
dBased on quartiles (I: <5.77 year μg/m3; II: 5.77-8.34 year μg/m3; III: 8.34-11.37 year μg/m3; IV:>11.37 year μg/m3) of the cumulative distribution in 
the population  
eBased on quartiles (I: <7.70 year μg/m3; II: 7.70-12.31 year μg/m3; III: 12.31-19.01 year μg/m3; IV:>19.01 year μg/m3) of the cumulative distribution 
in the population 
  
Table 4. Multi-pollutant model of risk of death from selected chronic diseases by lifetime cumulative exposure to rubber dust, 
rubber fumes, and Nitrosamines sum score in a cohort of rubber factory workers in the UK 
 
 N Cumulative Rubber Dust 
(year mg/m3) 
Cumulative Rubber Fumes 
(year mg/m3) 
Cumulative Nitrosamines Sum Score (NSS)a 
(year μg/m3) 
Exposureb SHRc 95%CI Exposured SHRc 95%CI Exposuree SHRc 95%CI 
Cerebrovascular 
 
 
 
2,795 I 1.00  I 1.00  I 1.00  
II 1.07 0.96 – 1.20 II 1.05 0.92 – 1.21 II 1.44 1.26 – 1.65 
III 1.11 0.99 – 1.25 III 1.09 0.94 – 1.27 III 1.35 1.19 – 1.54 
IV 0.94 0.81 – 1.08 IV 1.08 0.91 – 1.28 IV 1.17 1.01 – 1.37 
P for trend   0.10   0.11   0.29  
Circulatory 
 
 
 
14,627 
 
I 1.00  I 1.00  I 1.00  
II 1.09 1.04 – 1.15 II 1.04 0.98 – 1.11 II 1.20 1.13 – 1.27 
III 1.12 1.06 – 1.18 III 1.09 1.01 – 1.17 III 1.13 1.06 – 1.20 
IV 1.06 0.99 – 1.12 IV 1.08 1.00 – 1.16 IV 1.07 1.00 – 1.15 
P for trend   0.43   0.32   0.25  
Digestive 
 
 
 
827 I 1.00  I 1.00  I 1.00  
II 1.21 0.98 – 1.49 II 1.38 1.09 – 1.75 II 1.31 1.03 – 1.66 
III 1.11 0.90 – 1.38 III 1.13 0.86 – 1.49 III 1.40 1.12 – 1.75 
IV 1.08 0.84 – 1.40 IV 1.17 0.87 – 1.59 IV 1.20 0.91 – 1.57 
P for trend   0.56   0.06   0.46  
IHD 
 
 
 
9,349 I 1.00  I 1.00  I 1.00  
II 1.13 1.06 – 1.20 II 1.04 0.97 – 1.13 II 1.19 1.10 – 1.28 
III 1.16 1.09 – 1.23 III 1.10 1.00 – 1.20 III 1.10 1.02 – 1.18 
IV 1.08 1.00 – 1.17 IV 1.10 1.00 – 1.21 IV 1.01 0.93 – 1.10 
P for trend   0.80   0.73   0.37  
Respiratory 4,730 I 1.00  I 1.00  I 1.00  
  II 1.11 1.02 – 1.21 II 1.16 1.04 – 1.29 II 1.27 1.14 – 1.41 
  III 1.08 0.99 – 1.18 III 1.13 1.00 – 1.28 III 1.44 1.30 – 1.59 
  IV 0.91 0.81 – 1.01 IV 1.20 1.05 – 1.37 IV 1.12 0.99 – 1.27 
P for trend   0.80   0.76   0.27  
aSum of lifetime cumulative exposures to N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), N-nitrosodibutylamine, 
N-nitrosopiperidine (NPIP), and N-nitrosomorpholine (NMor) 
  
bBased on quartiles (I: <14.73 year mg/m3; II: 14.73-21.05 year mg/m3; III: 21.05-31.42 year mg/m3; IV:>31.42 year mg/m3) of the 
cumulative distribution in the population 
cSub-hazard ratio from competing risk survival analysis model adjusted for birth year 
dBased on quartiles (I: <4.89 year mg/m3; II: 4.89-6.96 year mg/m3; III: 6.96-11.61 year mg/m3; IV:>11.61 year mg/m3) of the 
cumulative distribution in the population 
eBased on quartiles (I: <17.24 year μg/m3; II: 17.24-26.72 year μg/m3; III: 26.72-546.51 year μg/m3; IV:>546.51 year μg/m3) of the 
cumulative distribution in the population 
 
 
